Culture accelerates and de-risks upstream process development for viral vectors by parallelizing experiments to reduce program bottlenecks.
Use our bioreactors to evaluate your viral vector constructs to get to your most desired outcome. Scaling-out your construct screening will save time and get you to your best outcome faster.
Generate material for downstream, drug product, and analytical activities. Outsource routine material supply to supplement your upstream capacity.
Analyze your vector product attributes with ddPCR, capsid ELISA, HCP, and HCDNA. Monitor your process with VCD, pH, and metabolites.